The French Government Defence procurement agency invests €900,000 towards Pherecydes Pharma managed €1.2-million project, involving several university and military laboratories.
Pherecydes Pharma is attending the Forum coorganised by PHAG ESPOIRS and LE LIEN associations, as well as their partners, Narbonne Hospital and City, on January 25, 2012 in Narbonne - France, at 9h15, in Le Théatre.
Biotech Finance press details the purpose of this investiment targeting the set up of a phage bioproduction unit and testing of 2 therapeutic products in human clinical trials.
Meeting the Belgian biotech companies at the 2011 Forum Bio-Entrepreneurs held in the Bourse de Commerce de Paris, December 6, 2011.
Phage Partnerships
Pharmaceutical partnership
Pherecydes Pharma is seeking a pharmaceutical laboratory to help financing the later Stage II and Stage III clinical development.
We are looking for a specialized Company to develop the companion diagnostic tests, in the frame of personalized medicine approach.
Sub-contracting
We are looking for a CRO that is specialized in data management of clinical trials and in the constitution of preclinical and clinical regulatory records, with experience in phage therapy.
In formulation, we are also searching for freeze-drying expertise in virus or phage based therapeutic products.